Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626243 · ClinicalTrials.gov registry record
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
A clinical trial of Non-Small Cell Lung Cancer, sponsored by Scientific Institute San Raffaele.
- Recruiting
- Registry status
- 140
- Enrollment target
- 6
- Study locations
NCT06626243 is a study of Non-Small Cell Lung Cancer that is actively recruiting participants, run by Scientific Institute San Raffaele. The registered enrollment target is 140 participants, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (79% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT06626243, a study of Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by Scientific Institute San Raffaele.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 6
- Study locations
Study Summary
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
Conditions Studied
Study Locations (6)
Other
- Scientific Institute Ospedale San Raffaele - Milan
- Regina Elena National Cancer Institute - Rome
Florida
- Baptist Health South Florida - Miami
New York
- Memorial Sloan Kettering Cancer Center - New York
West Virginia
- West Virginia University - Morgantown
Milan
- Istituto Clinico Humanitas - Rozzano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-09-30 |
| Est. Completion | 2025-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06626243
The ClinicalTrials.gov registry entry for NCT06626243 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (79% lower). The listed sponsor is Scientific Institute San Raffaele, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06626243 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06626243 about?
NCT06626243 is a clinical study titled "Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers". The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving...
What is the current status of trial NCT06626243?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2024-09-30. Estimated completion is 2025-10-15.
What conditions does trial NCT06626243 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
Who is sponsoring clinical trial NCT06626243?
This trial is sponsored by Scientific Institute San Raffaele, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626243 being conducted?
This trial has 6 study locations across Florida, New York, West Virginia, Milan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.